Selected article for: "abdominal pain and lung parenchyma"
Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017
  • Document date: 2017_11_7
    • ID: roslkxeq_342
    Snippet: Thirteen cats were selected for inclusion. Median age was 12 years (range 6-16 years) and median body weight 3.9 kg (range 3.1-8.2). Presenting clinical signs included coughing (9), tachypnea (5), gastrointestinal signs (4), abdominal pain (1) and lethargy (1) . A diffuse nodular pattern, consistent with metastasis to the lung parenchyma, was present in all cases: additional locations were identified in 6 cases (intrathoracic nodes [5], kidneys [.....
    Document: Thirteen cats were selected for inclusion. Median age was 12 years (range 6-16 years) and median body weight 3.9 kg (range 3.1-8.2). Presenting clinical signs included coughing (9), tachypnea (5), gastrointestinal signs (4), abdominal pain (1) and lethargy (1) . A diffuse nodular pattern, consistent with metastasis to the lung parenchyma, was present in all cases: additional locations were identified in 6 cases (intrathoracic nodes [5], kidneys [1] ). Medical treatments included vinorelbine (3), carboplatin (4), toceranib phosphate (4) and metronomic cyclophosphamide (2). All cats had variable improvement in clinical signs after initiation of treatment and experienced moderate to mild toxicity, with no cats requiring hospitalization due to adverse events.

    Search related documents:
    Co phrase search for related documents
    • adverse event and median age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adverse event and medical treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • clinical sign and median age: 1, 2, 3
    • clinical sign and medical treatment: 1
    • hospitalization require and median age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • hospitalization require and median body: 1
    • hospitalization require and medical treatment: 1, 2
    • median age and metronomic cyclophosphamide: 1
    • medical treatment and metronomic cyclophosphamide: 1